Personalizing Path-Specific Effects

Ilya Shpitser, Sourjya SarkararXiv 2017 · DOI · arXiv

Abstract

Unlike classical causal inference, which often targets the average causal effect of a treatment within a population, settings like personalized medicine require mapping individual characteristics to tailored treatments that maximize expected outcomes. This paper explores how unit characteristics can be used to design treatment strategies that maximize specific path-specific effects. For instance, in healthcare, one might wish to maximize a drug's direct chemical effect while holding adherence at a reference level. We define counterfactuals for path-specific policies, provide a complete identification algorithm, and demonstrate how machine learning classification—specifically Outcome Weighted Learning—can find high-quality policies. Our approach is validated through a simulation study.

Introduction

In modern medicine, understanding how a treatment works is as crucial as knowing if it works. Mediation analysis traditionally decomposes a treatment's total effect into direct and indirect pathways. However, standard methods focus on population averages, whereas personalized medicine seeks to tailor interventions to the individual.

A significant challenge arises when treatment effects are "entangled." In HIV care, for example, a drug's success is a function of both its biological efficacy and patient adherence. Simply maximizing the total effect might lead to choosing a drug that is easier to take but chemically inferior. This paper introduces a framework for "personalizing" mediation analysis, enabling researchers to find treatment policies that maximize a specific causal pathway while keeping others at a fixed reference level, tailored to a patient's unique profile.

Methodology: Identification and Optimization

The authors bridge graphical causal models with machine learning to solve the personalization problem.

Causal Identification with ADMGs

To represent complex relationships, including unobserved confounding, the framework utilizes Acyclic Directed Mixed Graphs (ADMGs). A core contribution is a general identification algorithm based on a "fixing operator," which determines if a path-specific effect is identifiable from available data. This algorithm is proven to be "complete," meaning if it cannot identify an effect, no non-parametric method can.

Causal graphs representing longitudinal treatment scenarios with mediators and unobserved confounding.

Path-Specific Policies

The authors define new counterfactuals that allow for interventions on specific edges of a causal graph. This allows for queries such as: "What treatment maximizes the outcome considering only the direct path $A \to Y$, ignoring the mediated path $A \to M \to Y$?"

Outcome Weighted Learning (OWL)

Policy discovery is reframed as a machine learning classification problem. Using Outcome Weighted Learning (OWL), the causal problem is transformed into a weighted classification task. Patients for whom a treatment $A=1$ yields a better path-specific outcome than $A=0$ for a specific patient are treated as training examples for the "1" class, with weights derived from the causal effects. The authors employ Support Vector Machines (SVMs) with linear and polynomial kernels to define these optimal decision boundaries.

Simulation Study

The approach was validated using a synthetic simulation mimicking a longitudinal HIV treatment scenario. The model included a two-stage treatment process ($A_1, A_2$) with intermediate mediators ($M_1, M_2$) and outcomes ($W_1, W_2$). Baseline features were 5-variate normal, while treatments and mediators were binary. This controlled environment allowed the authors to verify that the algorithm correctly optimized the intended path-specific counterfactuals, which are unobservable in real-world data.

Key Results and Insights

The simulation results highlighted the varying complexity of policy optimization across different stages of treatment.

Training accuracy results for Stage 1 and Stage 2 policies across different SVM kernels.
  • Stage 2 Optimization: The Stage 2 policy, benefiting from more available data, was highly optimizable. Training accuracies exceeded 99% when using high-degree polynomial kernels.
  • Stage 1 Challenges: Optimizing the initial treatment stage proved more difficult, with accuracies ranging from 65% to 83%. Interestingly, while complex kernels improved Stage 2 performance, they sometimes degraded Stage 1 results, indicating a risk of overfitting to noise when baseline information is the only input.
  • Disentangling Adherence: A key insight is the practical utility of this method in chronic disease management. By personalizing the chemical effect while controlling for adherence, clinicians can better distinguish between drug failure and behavioral challenges, allowing for more targeted interventions.

Conclusion

This work provides a robust mathematical foundation for personalizing path-specific effects. While the identification algorithm is powerful and complete, the practical success of the method depends on the inductive bias of the chosen classifier. Future work will explore more robust weighted classification algorithms to improve performance in early-stage decision-making where data is sparse and relationships are complex.

Summary updated

Abstract

Unlike classical causal inference, which often has an average causal effect of a treatment within a population as a target, in settings such as personalized medicine, the goal is to map a given unit's characteristics to a treatment tailored to maximize the expected outcome for that unit. Obtaining high-quality mappings of this type is the goal of the dynamic regime literature (Chakraborty and Moodie 2013), with connections to reinforcement learning and experimental design. Aside from the average treatment effects, mechanisms behind causal relationships are also of interest. A well-studied approach to mechanism analysis is establishing average effects along with a particular set of causal pathways, in the simplest case the direct and indirect effects. Estimating such effects is the subject of the mediation analysis literature (Robins and Greenland 1992; Pearl 2001). In this paper, we consider how unit characteristics may be used to tailor a treatment assignment strategy that maximizes a particular path-specific effect. In healthcare applications, finding such a policy is of interest if, for instance, we are interested in maximizing the chemical effect of a drug on an outcome (corresponding to the direct effect), while assuming drug adherence (corresponding to the indirect effect) is set to some reference level. To solve our problem, we define counterfactuals associated with path-specific effects of a policy, give a general identification algorithm for these counterfactuals, give a proof of completeness, and show how classification algorithms in machine learning (Chen, Zeng, and Kosorok 2016) may be used to find a high-quality policy. We validate our approach via a simulation study.
BibTeX
@misc{shpitser2017personalizing,
  author = {Ilya Shpitser and Sourjya Sarkar},
  title = {{Personalizing Path-Specific Effects}},
  year = {2017},
  eprint = {1709.03862},
  archivePrefix = {arXiv},
  url = {https://arxiv.org/abs/1709.03862},
}
Figure